Inmed pharmaceuticals reports full year fiscal 2021 financial results and provides business update

Vancouver, british columbia, sept. 24, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the manufacturing and clinical development of rare cannabinoids, today reported financial results for the fiscal year ended june 30, 2021.
INM Ratings Summary
INM Quant Ranking